Peer-reviewedCC BYBMJ open8 Oct 2026

Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.

Melissa K Shields¹
Richard J Woodman²
Stewart R Lake²
Laura E Downie³
Justine R Smith²

¹Flinders Health and Medical Research Institute, and College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia [email protected].
²Flinders Health and Medical Research Institute, and College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
³Department of Optometry and Vision Sciences, The University of Melbourne, Parkvile, Victoria, Australia.

A REAL-WORLD STUDY OF THE EFFECTIVENESS AND SAFETY OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOLLOWING TAFASITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Narendranath EPPERLA, Kim SAVERNO, Irina PIVNEVA +5
Hematology, Transfusion and Cell Therapy23 Oct 2026Peer-reviewedCC BYFull textOncologyDOAJ
Effectiveness of oral and inhaled repurposed and antiviral pharmaceutical treatments for acute SARS-CoV-2 in outpatient settings: a systematic review of 124 randomized trials.
Banafshe Hosseini, Lesley Anne Pablo, Jolanta Piszczek +4
BMC infectious diseases1 Jul 2026Peer-reviewedCC BYFull textInfectious diseaseEurope PMCDOAJ
BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF EFFICACY AND SAFETY
Isadora Medeiros ALMEIDA, Carolina Marsiglia LUCINI, Maria Fernanda Gonçalves Meirelles FERNANDES +5
Hematology, Transfusion and Cell Therapy23 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia
Angeline Josiah, Ryan Low, Alisha Ganesh +5
EJHaem1 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Relapsed/refractory PBML complicated with failed platelet implantation and mixed infection after allo-HSCT : A case report
Ying He, Fangyi Fan, Yingling Zhou +4
Medicine9 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{shields2026effectiveness,
  title = {{Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.}},
  author = {Melissa K Shields and Richard J Woodman and Stewart R Lake and Laura E Downie and Justine R Smith},
  journal = {BMJ open},
  year = {2026},
  month = oct,
  doi = {10.1136/bmjopen-2025-115420},
  url = {https://europepmc.org/article/MED/42849954},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.
AU  - Melissa K Shields
AU  - Richard J Woodman
AU  - Stewart R Lake
AU  - Laura E Downie
AU  - Justine R Smith
PY  - 2026
DA  - 2026/10/08
JO  - BMJ open
DO  - 10.1136/bmjopen-2025-115420
UR  - https://europepmc.org/article/MED/42849954
SN  - 2044-6055
ER  -

Related

Cite